Scholarlink

Background <p>Chronic kidney disease (CKD) is characterized by progressive renal fibrosis, which contributes to disease progression and ultimately leads to kidney failure. Circular RNAs (circRNAs) are key regulators in various fibrotic diseases, showing different expression patterns in different organs. However, the exact role and mechanisms of circRNAs in renal fibrosis are still not fully understood.</p> Methods <p>We analyzed circRNA expression in kidney tissues from unilateral ureteral obstruction (UUO) mice using RNA sequencing (RNA-seq). Bioinformatics analysis identified a significant downregulation of circG6pc in fibrotic kidneys. The role and mechanisms by which circG6pc inhibits renal fibrosis were explored both in vivo and in vitro. To further validate our findings, we employed gene overexpression and knockdown, along with immunohistochemistry, dual-luciferase reporter assays, RNA antisense purification (RAP) assays, RNA immunoprecipitation (RIP) assays, western blotting, and RT-qPCR.</p> Results <p>CircG6pc is significantly downregulated in fibrotic kidneys, and overexpression of circG6pc can notably improve renal fibrosis, mitochondrial dysfunction, and oxidative stress damage. Mechanistically, circG6pc acts as a sponge, directly binding to miR-7018-5p, thereby relieving its inhibitory effect on Aldh6a1 expression. The upregulation of Aldh6a1 promotes mitochondrial biogenesis, corrects mitochondrial dynamics imbalance, alleviates oxidative stress induced by mitochondrial dysfunction, and ultimately suppresses the progression of renal fibrosis.</p> Conclusions <p>These findings reveal the molecular mechanism by which circG6pc alleviates mitochondrial dysfunction and oxidative stress through the miR-7018-5p/Aldh6a1 axis, thereby inhibiting renal fibrosis. This provides a potential new strategy for the treatment of progressive CKD.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The novel circular RNA circG6pc attenuates oxidative stress and mitochondrial damage through miR-7018-5p/Aldh6a1 axis in kidney fibrosis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月5日

查看全文
  • Xiaojie Zhao,
  • Yufeng Xiong,
  • Xuke Qin,
  • Jianxin Hu,
  • Shiyu Huang,
  • Xinmiao Ni,
  • Jun Jian,
  • Song Yang,
  • Xiaodong Weng,
  • Hui Chen,
  • Zhiyuan Chen,
  • Xiuheng Liu,
  • Lei Wang

摘要

Background

Chronic kidney disease (CKD) is characterized by progressive renal fibrosis, which contributes to disease progression and ultimately leads to kidney failure. Circular RNAs (circRNAs) are key regulators in various fibrotic diseases, showing different expression patterns in different organs. However, the exact role and mechanisms of circRNAs in renal fibrosis are still not fully understood.

Methods

We analyzed circRNA expression in kidney tissues from unilateral ureteral obstruction (UUO) mice using RNA sequencing (RNA-seq). Bioinformatics analysis identified a significant downregulation of circG6pc in fibrotic kidneys. The role and mechanisms by which circG6pc inhibits renal fibrosis were explored both in vivo and in vitro. To further validate our findings, we employed gene overexpression and knockdown, along with immunohistochemistry, dual-luciferase reporter assays, RNA antisense purification (RAP) assays, RNA immunoprecipitation (RIP) assays, western blotting, and RT-qPCR.

Results

CircG6pc is significantly downregulated in fibrotic kidneys, and overexpression of circG6pc can notably improve renal fibrosis, mitochondrial dysfunction, and oxidative stress damage. Mechanistically, circG6pc acts as a sponge, directly binding to miR-7018-5p, thereby relieving its inhibitory effect on Aldh6a1 expression. The upregulation of Aldh6a1 promotes mitochondrial biogenesis, corrects mitochondrial dynamics imbalance, alleviates oxidative stress induced by mitochondrial dysfunction, and ultimately suppresses the progression of renal fibrosis.

Conclusions

These findings reveal the molecular mechanism by which circG6pc alleviates mitochondrial dysfunction and oxidative stress through the miR-7018-5p/Aldh6a1 axis, thereby inhibiting renal fibrosis. This provides a potential new strategy for the treatment of progressive CKD.

Graphical abstract